» Articles » PMID: 20005675

Neural Correlates of Reward Processing in Schizophrenia--relationship to Apathy and Depression

Overview
Journal Schizophr Res
Specialty Psychiatry
Date 2009 Dec 17
PMID 20005675
Citations 107
Authors
Affiliations
Soon will be listed here.
Abstract

The present study employs a new framework to categorise the heterogeneous findings on the relationship between impaired reward processing and negative and affective symptoms of schizophrenia. Based on previous behavioural and neuroimaging studies we postulate that "wanting" (i.e. anticipation) of a reward is specifically related to apathy, whereas "liking" (i.e. hedonic impact) is related to anhedonia and depression--symptoms commonly observed in schizophrenia. Fifteen patients with schizophrenia or schizoaffective disorder treated with atypical antipsychotic drugs and fifteen healthy controls performed a probabilistic monetary incentive delay task while undergoing functional magnetic resonance imaging. At the group level we found no significant differences between patients and controls in neural activation during anticipation or receipt of a reward. However, in patients with schizophrenia specific relationships between ventral-striatal activation and symptoms were observed. Ventral-striatal activation during reward anticipation was negatively correlated with apathy, while activation during receipt of reward was negatively correlated with severity of depressive symptoms. These results suggest that the link between negative symptoms and reward anticipation might specifically relate to apathy, i.e. a lack of motivation and drive. Impaired hedonic reward processing might contribute to the development of depressive symptoms in patients with schizophrenia, but it is not directly associated with self-rated anhedonia. These results indicate the necessity of more specifically differentiating negative and affective symptoms in schizophrenia in order to understand the role of the reward system in their pathogenesis.

Citing Articles

Corticolimbic circuitry as a druggable target in schizophrenia spectrum disorders: a narrative review.

Gee A, Dazzan P, Grace A, Modinos G Transl Psychiatry. 2025; 15(1):21.

PMID: 39856031 PMC: 11760974. DOI: 10.1038/s41398-024-03221-2.


Illness-related variables and abnormalities of resting-state brain activity in schizophrenia.

Giuliani L, Pezzella P, Giordano G, Fazio L, Mucci A, Perrottelli A Front Psychiatry. 2024; 15:1458624.

PMID: 39165501 PMC: 11333936. DOI: 10.3389/fpsyt.2024.1458624.


A systematic review of structural and functional magnetic resonance imaging studies on the neurobiology of depressive symptoms in schizophrenia spectrum disorders.

Gallucci J, Secara M, Chen O, Oliver L, Jones B, Marawi T Schizophrenia (Heidelb). 2024; 10(1):59.

PMID: 38961144 PMC: 11222445. DOI: 10.1038/s41537-024-00478-w.


Striatal Response to Reward Anticipation as a Biomarker for Schizophrenia and Negative Symptoms: Effects, Test-Retest Reliability, and Stability Across Sites.

Carruzzo F, Kaliuzhna M, Kuenzi N, Geffen T, Katthagen T, Schlagenhauf F Schizophr Bull. 2024; 50(4):733-746.

PMID: 38641344 PMC: 11283203. DOI: 10.1093/schbul/sbae046.


Neuronal Ensembles in the Infralimbic Cortex Dynamically Process Distinct Aspects of Hedonic Value.

Hurley S, Douton J, Carelli R J Neurosci. 2023; 43(47):8032-8042.

PMID: 37816597 PMC: 10669753. DOI: 10.1523/JNEUROSCI.0253-23.2023.